CRIS is strongly committed to training medical and research personnel, with the goal of positioning itself as the global vanguard in cancer research and treatment.
In 2017, the CRIS Foundation financed 10 research fellowships, lasting between six months and one year, to allow Spanish researchers travel to centres of reference abroad and acquire expertise and techniques that may advance research and therapies applied in Spain. In 2017, CRIS quadrupled the amount allocated to fellowships, currently set at 300,000 Euro.
The fellowships are provided via the following medical societies:
Spanish Society for Medical Oncology (Sociedad Española de Oncología Médica (SEOM)
The largest Spanish oncology society, with which CRIS began the Fellowship program in 2014. A total of three fellowships have been provided.
Read the news by clicking here. The investigators awarded the fellowships were:
- Dr Marc Oliva, of Hospital Durán i Reynals of the ICO Barcelona, who will go to Princess Margaret Cancer Center in Toronto, where he will study saliva and intestinal microbiota (mouth and gut flora) as response markers to immunotherapy in head and neck cancers.
- Dr Elena Castro, of the National Centre for Oncological Research (Centro Nacional de Investigaciones Oncológicas (CNIO)), will be working at Institute of Cancer Research in London, to identify the most aggressive mutations in prostate cancer, and to find new treatments through liquid biopsies.
Dr Robert Montal of the Hospital Clinic of Barcelona, will be staying at Mount Sinai Medical School in New York, where he will focus on seeking therapeutic targets in liver cancer, using the most advanced tools.
Spanish Society of Radiotherapy Oncology (Sociedad Española de Oncología Radioterápica (SEOR),
Which defends the crucial role of radiotherapy in treating cancer and in the latest advances. CRIS has provided the following fellowships through this society (click here to read the news item):
- Dr Marina Marbán Orejas will continue her training at Beatson Cancer Center in Glasgow after completing her final year as resident at University Hospital o Dr. Negrín in Las Palmas. There she will develop a research project focused on immunotherapy and its combination with radiotherapy.
- Dr Ángela Matías, of Navarra University Hospital, who will work at Gustave Roussy Cancer Campus in France, in a translational Radiotherapy-Oncology research project.
- Dr María Esperanza Rodríguez, of Salamanca University Hospital, who will continue her professional career in the field of Immuno-Radiotherapy at Weill Cornell University in New York, USA.
Spanish Society of Haematology and Haemotherapy (Sociedad Española de Hematología y Hemoterapia (SEHH)
A prestigious organisation that brings together more than 2500 haematologists in Spain. The following fellowships have been provided:
- Dr Cristina Jiménez Sánchez of Salamanca University Hospital, who will be working at the Steven P.Treon Centre at Boston’s Dana Farber Cancer Institute, where she will work on a brisk active clinical trial on Waldenström Macroglobulinaemia.
- Dr Julia Montoro Gómez, of Vall D’Hebron Institute of Oncology in Barcelona, who will be going to Columbia University in New York to perform a study on predicting response to treatment in patients with Myelodysplastic Syndrome.
Spanish Society of Paediatric Haemato- Oncology (Sociedad Española de Hematooncología Pediátrica (SEHOP)
Which attempts to improve and standardise treatments for children’s cancer. Together with SEHOP, the CRIS Foundation has provided the following fellowship:
- Dr Lucas Moreno Martín-Retortillo, of Hospital Niño Jesús, who will join Boston’s Dana Farber Cancer Institute, where he will acquire experience in developing drugs and Stage I and Stage II clinical trials.